Singapore markets closed

Santen Pharmaceutical Co., Ltd. (SNPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.260.00 (0.00%)
At close: 02:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
302,084,000
279,037,000
266,257,000
249,605,000
Cost of revenue
119,101,000
112,950,000
109,671,000
98,221,000
Gross profit
182,983,000
166,087,000
156,586,000
151,384,000
Operating expenses
Research development
24,823,000
28,297,000
26,377,000
24,112,000
Selling general and administrative
95,504,000
96,257,000
84,499,000
79,554,000
Total operating expenses
139,768,000
169,177,000
120,700,000
139,198,000
Operating income or loss
43,215,000
-3,090,000
35,886,000
12,186,000
Interest expense
1,771,000
1,499,000
1,209,000
1,488,000
Income before tax
39,353,000
-5,799,000
35,616,000
11,688,000
Income tax expense
11,668,000
9,184,000
8,427,000
2,562,000
Income from continuing operations
27,685,000
-14,983,000
27,189,000
9,126,000
Net income
27,729,000
-14,948,000
27,218,000
9,311,000
Net income available to common shareholders
27,729,000
-14,948,000
27,218,000
9,311,000
Basic EPS
69.51
-38.60
68.07
23.30
Diluted EPS
69.37
-38.60
67.97
23.26
Basic average shares
375,972
387,420
399,775
399,456
Diluted average shares
376,471
387,420
400,441
400,387